相关实验视频
Updated: Jan 17, 2026

04:50
An Acupoint Catgut-embedding Therapy for Treating Obesity
Published on: April 4, 2025
1.3K
关于医学治疗库辛综合征的最新情况
Brendan R Dillon1, Nidhi Agrawal1, Yair Schwarz2,3,4
1Holman Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, New York University Langone Medical Center, New York, NY, USA.
Drugs
|September 15, 2025
概括
当手术不是一种选择时,对库辛综合征 (CS) 的医学治疗至关重要. 目前的治疗方法阻断皮质醇的产生或作用,但对于库辛病 (CD) 需要更有针对性的治疗方法.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 库辛综合征 (CS) 管理通常涉及手术切除瘤.
- 医疗治疗对于不适合进行手术,有残留疾病或需要控制高皮质醇症的患者至关重要.
研究的目的:
- 审查目前针对库辛综合征的医疗疗法.
- 突出改善治疗方法的需要,特别是对于库辛病 (CD).
主要方法:
- 对CS现有的医疗治疗策略的审查.
- 对CS和CD目前治疗目标的分析.
- 讨论潜在的未来药物开发.
主要成果:
- 目前的CS治疗抑制皮质醇的产生或阻断葡萄糖皮质醇受体.
- CD疗法通过体静止素/多巴胺受体,DNA损伤或免疫激活向垂体瘤.
- 现有疗法需要优化疗效和减少副作用.
结论:
- 对CS的医疗管理至关重要,根据病因学和患者因素量身定制.
- 需要进一步的研究来开发更有效,更安全的CS和CD治疗方法.
相关概念视频
Adrenal Gland Disorders
2.9K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.9K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
Chronic Pancreatitis II: Collaborative Care
315
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
315
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Hypoglycemia and Glucagon
838
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
838
Cystic Fibrosis: Management
476
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
476

